Uribeta (Interferon Beta-1B)

Uribeta (Interferon Beta-1B) Uses, Dosage, Side Effects, Food Interaction and all others data.

Human interferon beta (165 residues), cysteine 17 is substituted with serine. Produced in E. coli, no carbohydrates, MW=18.5kD

Interferon beta upregulates the expression of MHC I proteins, allowing for increased presentation of peptides derived from viral antigens. This enhances the activation of CD8+ T cells that are the precursors for cytotoxic T lymphocytes (CTLs) and makes the macrophage a better target for CTL-mediated killing. Type I interferons also induce the synthesis of several key antiviral mediators including 2'-5' oligoadenylate synthetase (2'-5' A synthetase), beta-2 microglobulin, neopterin and protein kinase R.

Uribeta (Interferon Beta-1B)
Uses
Dosage
Side Effect
Precautions
Interactions
Uses during Pregnancy
Uses during Breastfeeding
Accute Overdose
Food Interaction
Half Life
Volume of Distribution
Clearance
Interaction With other Medicine
Contradiction
Storage

Trade Name	Uribeta (Interferon Beta-1B)
Generic	Interferon beta-1b
Interferon beta-1b Other Names	Interferon beta 1b (recombinant), Interferon beta-1b, Interferon beta-1b,recombinant, Interferon-beta-1b, Recombinant interferon beta-1b
Type
Formula	C₉₀₈H₁₄₀₈N₂₄₆O₂₅₃S₆
Weight	20011.0 Da
Groups	Approved
Therapeutic Class
Manufacturer
Available Country	Dominican Republic, El Salvador, Guatemala, Honduras, Mexico
Last Updated:	September 19, 2023 at 7:00 am

Uses

Uribeta (Interferon Beta-1B) is a form of recombinant human interferon used to slow the progression of relapsing multiple sclerosis and to reduce the frequency of clinical symptoms.

Uribeta (Interferon Beta-1B) is a drug used for the treatment of relapsing/remitting multiple sclerosis. It has been shown to slow the advance of the disease as well as to decrease the frequency of attacks.

Uribeta (Interferon Beta-1B) is also used to associated treatment for these conditions: Relapsing Remitting Multiple Sclerosis (RRMS), Secondary Progressive Multiple Sclerosis (SPMS)

How Uribeta (Interferon Beta-1B) works

Interferon beta binds to type I interferon receptors (IFNAR1 and IFNAR2c) which activate two Jak (Janus kinase) tyrosine kinases (Jak1 and Tyk2). These transphosphorylate themselves and phosphorylate the receptors. The phosphorylated INFAR receptors then bind to Stat1 and Stat2 (signal transducers and activators of transcription)which dimerize and activate multiple (~100) immunomodulatory and antiviral proteins. Interferon beta binds more stably to type I interferon receptors than interferon alpha.

Food Interaction

Avoid excessive or chronic alcohol consumption. Alcohol and Interferon beta-1 can both cause hepatoxicity, therefore if they are used together they may have additive hepatoxic effects.